Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
100
-
Total 13F shares, excl. options
-
29.1M
-
Shares change
-
+2.4M
-
Total reported value, excl. options
-
$565M
-
Value change
-
+$45.7M
-
Number of buys
-
63
-
Number of sells
-
-32
-
Price
-
$19.46
Significant Holders of Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (MIRM) as of Q2 2022
117 filings reported holding MIRM - Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q2 2022.
Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (MIRM) has 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.1M shares
of 50.5M outstanding shares and own 57.71% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4.19M shares), Frazier Life Sciences Management, L.P. (3.57M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.24M shares), Novo Holdings A/S (2.03M shares), RiverVest Venture Management LLC (1.92M shares), Rock Springs Capital Management LP (1.72M shares), BlackRock Inc. (1.4M shares), CADIAN CAPITAL MANAGEMENT, LP (1.39M shares), FRANKLIN RESOURCES INC (1.25M shares), and Polar Capital Holdings Plc (1.21M shares).
This table shows the top 100 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.